Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"
Trial details
- Registry ID
- NCT04204252
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Kamada alpha 1-antitrypsin for inhalation
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"NCT04204252 | KMDA | Phase 3 | Terminated | 2026-02-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |